Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0956-2025

muRata Vios Monitoring System Model 2050; bedside cardiac monitor, including cardiotachometer and alarm rate Recall

muRata Vios Monitoring System Model 2050; bedside cardiac monitor, including cardiotachometer and alarm rate

FDA recall Class II

Completed

FDA lists this Class II recall for muRata Vios Monitoring System Model 2050; bedside cardiac monitor, including cardiotachometer and alarm rate. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0956-2025
Recall classification
Class II
Enforcement status
Completed
Initiation date
Jun 21, 2021
FDA report date
Jan 22, 2025
Quantity in commerce
275 units
Distribution
See key details
FDA cause
Device Design

What is being recalled?

muRata Vios Monitoring System Model 2050; bedside cardiac monitor, including cardiotachometer and alarm rate

Affected model & UDI checker

Search the exact identifiers published for Z-0956-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
2050muRata Vios Monitoring System Model 2050; bedside cardiac monitor, including cardiotachometer and alarm rateCheck source noticeNot specified
FDA code information

Soft ware version 1.49.02 UDI: +B595BSM20500/\$\$7V1.49.02/16D20200504S and Software version 1.52.00 UDI: +B595BSM20500/\$\$7V1.52.00/16D20210305K

View the original FDA recall notice

Why was this product recalled?

During the set-up and workflow to begin Vios monitoring, it has been noticed that patient vital signs and ECG waveforms can become distorted and will flicker or flash very fast. This issue only occurs on the Central Station Monitor (CSM) in the patient tiles view and is not seen at any other point during patient monitoring & not on the Bedside Monitor.

What actions did Murata Vios, Inc. take?

Murata Vios notified their consignees via email on 06/21/2021. The notice explained the issue and provided workflow guidance to prevent the problem from occurring while a software update was being created. The firm followed up with another email on 08/24/2021 informing the consignees that the software update was ready for deployment and to request scheduling an appointment for the upgrade.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology